All In MedTech

Device Trial Radar · NCT07089355

Study Evaluating Toro 88 Super Bore Aspiration Catheter for Acute Ischemic Stroke

Open-Label, Single-Arm Study Evaluating Toro 88 Super Bore Aspiration Catheter Safety and Efficacy in Mechanical Thrombectomy for Acute Ischemic Stroke in France

Last checked: Nov 20, 2026Latest source record: Jul 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Jul 2025

Primary completion

Dec 2025

Study completion Mar 2026

Sponsor

Lead sponsor
Toro Neurovascular, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 28, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this pilot study is to evaluate the safety and efficacy of the Toro 88 Super Bore Aspiration Catheter in acute ischemic stroke patients.

Conditions

  • Acute Ischemic Stroke

Interventions

  • Toro 88 Super Bore Aspiration CatheterDevice

    The Toro 88 Super Bore Aspiration Catheter is a neurovascular device designed for clot aspiration during mechanical thrombectomy procedures.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events that may be associated with the use of the experimental device at 24-36hTime frame: From start of procedure to 24-36 hours post-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hôpital Fondation Adolphe de Rothschild

    Paris, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.